Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

News Conference News

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

Shelley Wood

November 19, 2020

News Conference News AHA 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Shelley Wood

November 15, 2020

Presentation TCT 2020

TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

Presenter: Markus Krackhardt

October 14, 2020

Presentation TCT 2020

TCT 267: BIOVITESSE – Multicenter Prospective First-In-Man Study of a New Polymer Free Drug-coated Stent With Ultrathin Struts: Clinical Study Outcome

Presenter: Lorenz Raber

October 14, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Daily News

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Michael O'Riordan

July 07, 2020

News Conference News CRT 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Michael O'Riordan

February 25, 2020

Advertisement

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

TCT 267: BIOVITESSE – Multicenter Prospective First-In-Man Study of a New Polymer Free Drug-coated Stent With Ultrathin Struts: Clinical Study Outcome

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content